Literature DB >> 33560374

Platelet reactivity to thrombin differs between patients with COVID-19 and those with ARDS unrelated to COVID-19.

Younes Zaid1,2,3, Fadila Guessous4,5, Florian Puhm6,7, Wail Elhamdani1, Lamyae Chentoufi1, Andrew Conway Morris8, Amine Cheikh1, Farid Jalali9, Eric Boilard6,7, Louis Flamand6,7.   

Abstract

Entities:  

Year:  2021        PMID： 33560374     DOI： 10.1182/bloodadvances.2020003513

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  15 in total

1.  Cytokines and Lipid Mediators of Inflammation in Lungs of SARS-CoV-2 Infected Mice.

Authors:  Isabelle Dubuc; Julien Prunier; Émile Lacasse; Annie Gravel; Florian Puhm; Isabelle Allaeys; Anne-Sophie Archambault; Leslie Gudimard; Rosaria Villano; Arnaud Droit; Nicolas Flamand; Éric Boilard; Louis Flamand
Journal:  Front Immunol       Date:  2022-06-24       Impact factor: 8.786

2.  Thrombotic Events in COVID-19 Are Associated With a Lower Use of Prophylactic Anticoagulation Before Hospitalization and Followed by Decreases in Platelet Reactivity.

Authors:  Chantal C Clark; Bernard N Jukema; Arjan D Barendrecht; Judith S Spanjaard; Nikita K N Jorritsma; Simone Smits; Steven de Maat; Cor W Seinen; Sandra Verhoef; Naomi M J Parr; Silvie A E Sebastian; Arnold C Koekman; Annet C W van Wesel; Harriet M R van Goor; Roy Spijkerman; Suzanne H Bongers; Erhard van der Vries; Stefan Nierkens; Marianne Boes; Leo Koenderman; Karin A H Kaasjager; Coen Maas
Journal:  Front Med (Lausanne)       Date:  2021-04-22

3.  Platelet-driven coagulopathy in COVID-19 patients: in comparison to seasonal influenza cases.

Authors:  Jianguo Zhang; Xing Huang; Daoyin Ding; Zhimin Tao
Journal:  Exp Hematol Oncol       Date:  2021-05-31

4.  Severe COVID-19 is marked by dysregulated serum levels of carboxypeptidase A3 and serotonin.

Authors:  Rodolfo Soria-Castro; Yatsiri G Meneses-Preza; Gloria M Rodríguez-López; Sandra Romero-Ramírez; Víctor A Sosa-Hernández; Rodrigo Cervantes-Díaz; Alfredo Pérez-Fragoso; José J Torres-Ruíz; Diana Gómez-Martín; Marcia Campillo-Navarro; Violeta D Álvarez-Jiménez; Sonia M Pérez-Tapia; Alma D Chávez-Blanco; Sergio Estrada-Parra; José L Maravillas-Montero; Rommel Chacón-Salinas
Journal:  J Leukoc Biol       Date:  2021-05-31       Impact factor: 6.011

Review 5.  Platelets in Viral Infections - Brave Soldiers or Trojan Horses.

Authors:  Waltraud C Schrottmaier; Anna Schmuckenschlager; Anita Pirabe; Alice Assinger
Journal:  Front Immunol       Date:  2022-03-28       Impact factor: 7.561

6.  Impact of Plasma 5 Hydroxyindoleacetic Acid, a Serotonin Metabolite, on Clinical Severity in Acute Respiratory Distress Syndrome.

Authors:  Takeshi Tanaka; Masahiko Mori; Masato Tashiro; Koichi Izumikawa
Journal:  Front Med (Lausanne)       Date:  2021-12-16

Review 7.  SARS-CoV-2 involvement in central nervous system tissue damage.

Authors:  Muhammad Ali Haidar; Zaynab Shakkour; Mohammad Amine Reslan; Nadine Al-Haj; Perla Chamoun; Karl Habashy; Hasan Kaafarani; Shima Shahjouei; Sarah H Farran; Abdullah Shaito; Esber S Saba; Bassam Badran; Mirna Sabra; Firas Kobeissy; Maya Bizri
Journal:  Neural Regen Res       Date:  2022-06       Impact factor: 5.135

8.  Chemokines and eicosanoids fuel the hyperinflammation within the lungs of patients with severe COVID-19.

Authors:  Younes Zaid; Étienne Doré; Isabelle Dubuc; Anne-Sophie Archambault; Olivier Flamand; Michel Laviolette; Nicolas Flamand; Éric Boilard; Louis Flamand
Journal:  J Allergy Clin Immunol       Date:  2021-06-07       Impact factor: 10.793

9.  Unprovoked serotonin syndrome-like presentation of SARS-CoV-2 infection: A small case series.

Authors:  Philip Keith; Marc Saint-Jour; Frank Pusey; Jeremy Hodges; Farid Jalali; L Keith Scott
Journal:  SAGE Open Med Case Rep       Date:  2021-07-08

10.  The ongoing enigma of SARS-CoV-2 and platelet interaction.

Authors:  Younes Zaid; Fadila Guessous
Journal:  Res Pract Thromb Haemost       Date:  2022-01-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.